THERMO FISHER SCIENTIFIC INC
For the period ended Mar 30, 2024. Filed May 3, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2024 · Filed May 3, 2024
TMO$718.20-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three months ended | ||
|---|---|---|
| March 30, | April 1, | |
| (In millions) | 2024 | 2023 |
| Operating activities | ||
| Net income | $1,331 | $1,292 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation of property, plant and equipment | 285 | 253 |
| Amortization of acquisition-related intangible assets | 551 | 606 |
| Change in deferred income taxes | (253) | (146) |
| Stock-based compensation | 70 | 76 |
| Other non-cash expenses, net | 53 | 181 |
| Changes in assets and liabilities, excluding the effects of acquisitions | (787) | (1,533) |
| Net cash provided by operating activities | 1,251 | 729 |
| Investing activities | ||
| Purchases of property, plant and equipment | (347) | (458) |
| Proceeds from sale of property, plant and equipment | 4 | 6 |
| Proceeds from cross-currency interest rate swap interest settlements | 64 | 2 |
| Acquisitions, net of cash acquired | — | (2,704) |
| Purchases of investments | (1,758) | (2) |
| Other investing activities, net | 7 | 14 |
| Net cash used in investing activities | (2,030) | (3,142) |
| Financing activities | ||
| Net proceeds from issuance of debt | 1,205 | — |
| Proceeds from issuance of commercial paper | — | 1,027 |
| Repayments of commercial paper | — | (523) |
| Purchases of company common stock | (3,000) | (3,000) |
| Dividends paid | (135) | (117) |
| Other financing activities, net | 110 | 20 |
| Net cash used in financing activities | (1,821) | (2,593) |
| Exchange rate effect on cash | 22 | (31) |
| Decrease in cash, cash equivalents and restricted cash | (2,578) | (5,037) |
| Cash, cash equivalents and restricted cash at beginning of period | 8,097 | 8,537 |
| Cash, cash equivalents and restricted cash at end of period | $5,519 | $3,500 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.